cabozantinib (MedChemExpress)
Structured Review
Cabozantinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cabozantinib/Cabozantinib/pmc13132380-304-2-20
Average 94 stars, based on 49 article reviews
Images
Related Articles
Irradiation:Article Title: Cabozantinib Sensitizes NSCLC Cells to Radiation by Inducing Ferroptosis via STAT3/MCL1/BECN1/SLC7A11 Axis Suppression Article Snippet: Mycoplasma contamination was routinely monitored using the EZPCR Mycoplasma Test Kit (Biological Industries, Beit HaEmek, Israel). .. Cells were treated with the indicated concentrations of other:Article Title: VOPP1, a determinant of the sensitivity of non-small cell lung cancer cells to NAE inhibitors. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Tumor Implantation:Article Title: The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma. Article Snippet: .. Two weeks after tumor implantation, mice were divided into groups according to tumor volume and administered either celecoxib (10 mg/kg, intraperitoneally, once daily; MedChemExpress, NJ, USA) [17,18] or In Vivo:Article Title: Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcription. Article Snippet: AB521 (casdatifan) (Hardman et al., 2025; Mata et al., 2025), MK-6482/PT2977 (belzutifan) (Xu et al., 2019), and PT2385 (Wehn et al., 2018) were synthesized by Arcus Biosciences and dissolved in 100% DMSO prior to in vitro use and formulated for in vivo studies as indicated under the mouse xenograft models subsection. .. For mouse in vivo studies, purified human anti-PD-1 antibody (zimberelimab, zim) (Lou et al., 2021; Markham, 2021) was supplied by Arcus Biosci- ences, whereas purified human IgG4 isotype control antibody (CrownVivo human IgG4, MBL International) and Purification:Article Title: Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcription. Article Snippet: AB521 (casdatifan) (Hardman et al., 2025; Mata et al., 2025), MK-6482/PT2977 (belzutifan) (Xu et al., 2019), and PT2385 (Wehn et al., 2018) were synthesized by Arcus Biosciences and dissolved in 100% DMSO prior to in vitro use and formulated for in vivo studies as indicated under the mouse xenograft models subsection. .. For mouse in vivo studies, purified human anti-PD-1 antibody (zimberelimab, zim) (Lou et al., 2021; Markham, 2021) was supplied by Arcus Biosci- ences, whereas purified human IgG4 isotype control antibody (CrownVivo human IgG4, MBL International) and Control:Article Title: Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcription. Article Snippet: AB521 (casdatifan) (Hardman et al., 2025; Mata et al., 2025), MK-6482/PT2977 (belzutifan) (Xu et al., 2019), and PT2385 (Wehn et al., 2018) were synthesized by Arcus Biosciences and dissolved in 100% DMSO prior to in vitro use and formulated for in vivo studies as indicated under the mouse xenograft models subsection. .. For mouse in vivo studies, purified human anti-PD-1 antibody (zimberelimab, zim) (Lou et al., 2021; Markham, 2021) was supplied by Arcus Biosci- ences, whereas purified human IgG4 isotype control antibody (CrownVivo human IgG4, MBL International) and CCK-8 Assay:Article Title: Integrated Multi‐Omics Profiling to Characterize Molecular Subtypes and Reveal Potential Therapeutic Strategies for Colorectal Cancer Article Snippet: CRC cells were plated in 96‐well plates (Corning, USA) at a density of 5 × 104 cells per well in 100 μL of medium and left to incubate overnight. .. Cells were exposed to different concentrations of Alisertib, Dasatinib, Temozolomide, Olaparib, BX‐912, and Incubation:Article Title: Integrated Multi‐Omics Profiling to Characterize Molecular Subtypes and Reveal Potential Therapeutic Strategies for Colorectal Cancer Article Snippet: CRC cells were plated in 96‐well plates (Corning, USA) at a density of 5 × 104 cells per well in 100 μL of medium and left to incubate overnight. .. Cells were exposed to different concentrations of Alisertib, Dasatinib, Temozolomide, Olaparib, BX‐912, and |
